<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="11" family="Times" color="#000000"/>
	<fontspec id="1" size="10" family="Times" color="#000000"/>
	<fontspec id="2" size="10" family="Times" color="#000000"/>
<text top="72" left="155" width="305" height="16" font="0"><b>ENCODE Antibody Validation Documentation </b></text>
<text top="89" left="126" width="364" height="16" font="0"><b>Transcription factor: FOS-like antigen 2 (GeneID 2355) </b></text>
<text top="105" left="77" width="3" height="13" font="1"><b> </b></text>
<text top="118" left="77" width="344" height="13" font="1"><b>From:  Myers Lab, HudsonAlpha Institute for Biotechnology </b></text>
<text top="132" left="77" width="340" height="13" font="1"><b>Contact Person:</b> Dr. Florencia Pauli (fpauli@hudsonalpha.org) </text>
<text top="146" left="77" width="3" height="13" font="2"> </text>
<text top="160" left="77" width="3" height="13" font="2"> </text>
<text top="174" left="77" width="296" height="13" font="1"><b>Transcription factor:</b> FOSL2 (GeneID 2355; ~35 kDa) </text>
<text top="187" left="77" width="3" height="13" font="1"><b> </b></text>
<text top="201" left="77" width="322" height="13" font="1"><b>Antibody:</b> Fra-2 (Q-20), Santa Cruz Biotechnology (sc-604) </text>
<text top="215" left="77" width="417" height="13" font="2">Rabbit polyclonal, epitope mapping at the N-terminus of Fra-2 of human origin </text>
<text top="229" left="77" width="354" height="13" font="2">Web: http://www.scbt.com/datasheet-604-fra-2-q-20-antibody.html </text>
<text top="243" left="77" width="3" height="13" font="2"> </text>
<text top="256" left="77" width="3" height="13" font="2"> </text>
<text top="270" left="77" width="236" height="16" font="0"><b>Validation 1: Immunoblot Analysis  </b></text>
<text top="296" left="77" width="467" height="13" font="2">For an antibody to meet ENCODE validation standards, a single band of the predicted </text>
<text top="310" left="77" width="467" height="13" font="2">size,  or  a  band  of  no  less  than  half  the  total  signal,  must  be  detected  in  a  lane  on  a </text>
<text top="324" left="77" width="74" height="13" font="2">Western blot. </text>
<text top="348" left="77" width="3" height="13" font="2"> </text>
<text top="371" left="77" width="187" height="13" font="1"><b>a.  Vendor immunoblot analysis  </b></text>
<text top="544" left="206" width="3" height="13" font="2"> </text>
<text top="565" left="81" width="422" height="13" font="1"><b>Figure Legend:</b> Western blot analysis of Fra-2 expression in NIH/3T3 nuclear </text>
<text top="579" left="81" width="358" height="13" font="2">extracts (A, B). Fra-2 (Q-20) antibody (sc-604) is tested in lane (B). </text>
<text top="603" left="81" width="3" height="13" font="2"> </text>
<text top="627" left="81" width="3" height="13" font="1"><b> </b></text>
<text top="650" left="81" width="3" height="13" font="1"><b> </b></text>
<text top="674" left="90" width="3" height="13" font="1"><b> </b></text>
<text top="698" left="81" width="203" height="13" font="1"><b>b.  Myers Lab immunoblot analysis</b> </text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="72" left="77" width="131" height="13" font="1"><b>Western blot protocol  </b></text>
<text top="96" left="77" width="467" height="13" font="2">Whole cell lysates were immunoprecipitated using primary antibody, and the IP fraction </text>
<text top="110" left="77" width="467" height="13" font="2">was  loaded  on  a  12%  acrylamide  gel  and  separated  with  a  Bio-Rad  PROTEAN  II  xi </text>
<text top="124" left="77" width="467" height="13" font="2">system.  After  separation,  the  samples  were  transferred  to  a  nitrocellulose  membrane </text>
<text top="138" left="77" width="467" height="13" font="2">using  a  Bio-Rad  Trans-Blot  Electrophoretic  Transfer  system.    Standard  western  blot </text>
<text top="151" left="77" width="467" height="13" font="2">protocol was used to probe the membrane with the primary antibody (same antibody as </text>
<text top="165" left="77" width="467" height="13" font="2">used  for  IP),  and  an  HRP-conjugated  secondary  antibody  and  SuperSignal  West </text>
<text top="179" left="77" width="467" height="13" font="2">Femto  solution  (Thermo  Scientific)  were  used  to  detect  the  immunoprecipitated </text>
<text top="193" left="77" width="59" height="13" font="2">proteins.    </text>
<text top="512" left="77" width="3" height="13" font="2"> </text>
<text top="512" left="532" width="3" height="13" font="2"> </text>
<text top="534" left="122" width="354" height="13" font="1"><b>Figure  Legend:</b>  FOSL2  immunoblot:  IP-western  with  sc-604 </text>
<text top="547" left="122" width="354" height="13" font="2">FOSL2  antibody  in  whole  cell  lysates  of,  left  to  right:  GM12878, </text>
<text top="561" left="122" width="354" height="13" font="2">HeLa, HepG2, and K562. Heavy chain and light chain of IgG are </text>
<text top="575" left="122" width="272" height="13" font="2">indicated, and Fra-2 band is indicated at ~40 kDa.  </text>
<text top="599" left="77" width="3" height="13" font="2"> </text>
<text top="623" left="77" width="3" height="13" font="2"> </text>
<text top="646" left="77" width="167" height="16" font="0"><b>Validation 2: In progress </b></text>
</page>
</pdf2xml>
